meglumine has been researched along with pentamidine in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (13.33) | 18.7374 |
| 1990's | 14 (46.67) | 18.2507 |
| 2000's | 10 (33.33) | 29.6817 |
| 2010's | 2 (6.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Loewe, H; Raether, W; Seidenath, H | 1 |
| de Benoist, B; Gardéa, A; Haarscher, A; Kien, T; Rohmer, A | 1 |
| Bigaignon, G; Cornu, G; Mattot, M; Ninane, J; Vermylen, C | 1 |
| Croft, SL; Frommel, D; Gebre-Hiwot, A; Tadesse, G | 1 |
| Castillo, R; Hernández-Quero, J; Jiménez, E; Medrano, FJ; Pineda, JA; Reyes, MJ; Rivero, A; Sánchez-Quijano, A; Velez, ID; Viciana, P | 1 |
| Balafrej, A; Baroudi, A; Benhamou, B; Mikou, N; Mikou, S | 1 |
| Casillas, A; Costa, JR; de Dios Garcia, J; del Mar Sanz, M; Guijarro, C; Martinez, R; Rubio, R | 1 |
| Dumas, ML; Dumas, R; Morin, D; Valette, H | 1 |
| Anciaux, ML; Bourée, P; Taugourdeau, P | 1 |
| Tsetentis, Y | 1 |
| Buffet, P; Caumes, E; Gentilini, M | 1 |
| Alcácer, F; Aznar, J; Colomina, J; Ferriols, F; Magraner, J; Orovitg, F; Rodilla, F | 1 |
| Belec, L; Bouree, P | 1 |
| Berman, JD; Grogl, M; Soto-Mancipe, J | 1 |
| Blanchot, I; Dabadie, A; Degeilh, B; Guiguen, C; Mauny, I; Roussey, M | 1 |
| Ozsoylu, S | 1 |
| Dumon, H; Gambarelli, F; Garnier, JM; Kaplanski, S; Piarroux, R; Unal, D | 1 |
| Astier, A; Bories, C; Deniau, M; Durand, R; Fusai, T; Houin, R; Paul, M; Rivollet, D | 1 |
| Holzmuller, P; Lemesre, JL; Sereno, D | 1 |
| Banzet, S | 1 |
| Delgado, G; Moreno, A; Patarroyo, ME; Puentes, F | 1 |
| Andersen, EM; Berman, JD; Colina, O; Cruz-Saldarriaga, M; Echevarria, J; Llanos-Cuentas, A; Luz-Cjuno, M; Miranda-Verastegui, C | 1 |
| Aguado, JM; Costa, JR; López-Medrano, F; Rodriguez-Peralto, JL | 1 |
| Amato, VS; Neto, VA; Nicodemo, AC; Siqueira, AM; Tuon, FF | 1 |
| Amato Neto, V; Amato, VS; Graf, ME; Nicodemo, AC; Siqueira, AM; Tuon, FF | 1 |
| Barnabas, GA; Morrone, A; Padovese, V; Terranova, M; Toma, L | 1 |
| García-Lázaro, M; Natera, C; Rivero, A; Villar, C | 1 |
| Abegão de Camargo, R; Amato, VS; Duarte, MI; Imamura, R; Neto, VA; Tuon, FF | 1 |
| Dorlo, TP; Kager, PA | 1 |
| Cesetti, MV; de Morais, OO; Gomes, CM; Mendes, MS; Roselino, AM; Sampaio, RN | 1 |
4 review(s) available for meglumine and pentamidine
| Article | Year |
|---|---|
[Treatment of localized cutaneous leishmaniasis].
Topics: Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Humans; Itraconazole; Ketoconazole; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentamidine | 1994 |
Leishmaniasis: report of 33 cases and a review of the literature.
Topics: Allopurinol; Animals; Child, Preschool; Disease Reservoirs; Female; Global Health; Humans; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Male; Meglumine; Pentamidine; Protozoan Vaccines | 1993 |
Treatment of mucosal leishmaniasis in Latin America: systematic review.
Topics: Amphotericin B; Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Humans; Itraconazole; Latin America; Leishmania; Leishmaniasis, Mucocutaneous; Meglumine; Paromomycin; Pentamidine | 2007 |
Treatment of New World cutaneous leishmaniasis--a systematic review with a meta-analysis.
Topics: Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Developing Countries; Endemic Diseases; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Paromomycin; Pentamidine | 2008 |
2 trial(s) available for meglumine and pentamidine
| Article | Year |
|---|---|
Evaluation of pentamidine for the treatment of cutaneous leishmaniasis in Colombia.
Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Colombia; Follow-Up Studies; Humans; Injections, Intramuscular; Itraconazole; Ketoconazole; Leishmaniasis, Cutaneous; Male; Meglumine; Pentamidine; Treatment Outcome | 1993 |
Comparison of meglumine antimoniate and pentamidine for peruvian cutaneous leishmaniasis.
Topics: Adult; Animals; Antiprotozoal Agents; Female; Humans; Infusions, Intravenous; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentamidine; Peru; Treatment Outcome | 2005 |
24 other study(ies) available for meglumine and pentamidine
| Article | Year |
|---|---|
Action of p-(4-amidino-phenoxy)-benzaldehyde-p-amidino-phenylhydrazone dihydrochloride on Leishmania donovani infections in the golden hamster.
Topics: Amidines; Animals; Antimony; Antimony Sodium Gluconate; Cricetinae; Drug Evaluation, Preclinical; Leishmaniasis, Visceral; Liver; Meglumine; Mesocricetus; Pentamidine | 1978 |
[Visceral leishmaniasis in 2 siblings and their father].
Topics: Adult; Antimony; Child; Female; France; Humans; Leishmaniasis, Visceral; Male; Meglumine; Pentamidine | 1978 |
Visceral and cutaneous leishmaniasis in an European paediatric population.
Topics: Animals; Antiprotozoal Agents; Bone Marrow; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Leishmania; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentamidine | 1992 |
An in vitro model for screening antileishmanial drugs: the human leukaemia monocyte cell line, THP-1.
Topics: Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Drug Evaluation, Preclinical; Humans; Leishmania; Leishmania donovani; Leukemia, Monocytic, Acute; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Paromomycin; Pentamidine; Species Specificity; Tumor Cells, Cultured | 1992 |
Visceral leishmaniasis in HIV-1-infected individuals: a common opportunistic infection in Spain?
Topics: Adult; AIDS-Related Opportunistic Infections; Allopurinol; Antiprotozoal Agents; CD4-Positive T-Lymphocytes; Female; HIV-1; Hospitals, University; Humans; Leishmaniasis, Visceral; Leukocyte Count; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentamidine; Retrospective Studies; Spain; Treatment Outcome | 1992 |
[Infantile visceral leishmaniasis in Morocco. A review of 67 cases managed at the Rabat Hospital for children (1979-1988)].
Topics: Adolescent; Age Factors; Antimony Sodium Gluconate; Bone Marrow Examination; Child; Child, Preschool; Diagnosis, Differential; Drug Therapy, Combination; Female; Fluorescent Antibody Technique; Hospitals, Pediatric; Humans; Infant; Leishmaniasis, Visceral; Male; Meglumine; Morocco; Pentamidine; Retrospective Studies; Survival Rate; Treatment Outcome | 1991 |
Visceral leishmaniasis in HIV-infected patients.
Topics: Adult; Amphotericin B; Antiprotozoal Agents; Female; HIV Infections; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentamidine; Spain; Treatment Outcome | 1991 |
[Transitory acute kidney insufficiency and insulin-dependent after treatment of kala-azar with pentamidine and N-methylglucamine antimony].
Topics: Acute Kidney Injury; Antimony; Antiprotozoal Agents; Child, Preschool; Diabetes Mellitus, Type 1; Humans; Leishmaniasis, Visceral; Male; Meglumine; Nephrotic Syndrome; Pentamidine | 1991 |
[Methylglucamine antimoniate and sodium stibogluconate in the treatment of leishmaniasis. Study of 16 cases].
Topics: Adolescent; Adult; Antimony; Antimony Sodium Gluconate; Child; Child, Preschool; Female; Gluconates; Humans; Infant; Leishmaniasis; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentamidine; Splenectomy | 1985 |
[Treatment of visceral leishmaniasis].
Topics: Animals; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Drug Resistance, Microbial; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Mice; Organometallic Compounds; Pentamidine | 1985 |
Amphotericin B for visceral leishmaniasis resistant to pentavalent antimonial drugs in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antimony; Antiprotozoal Agents; Drug Resistance; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentamidine; Substance Abuse, Intravenous | 1994 |
[Visceral leishmaniasis in an infant in Brittany: discussion on the modes of transmission out endemic zones].
Topics: France; Humans; Infant; Leishmaniasis, Visceral; Male; Meglumine; Pentamidine; Transfusion Reaction | 1993 |
Treatment of kala azar.
Topics: Antimony; Antiprotozoal Agents; Drug Therapy, Combination; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentamidine | 1996 |
[Resistance of Leishmania infantum to Glucantime: risk factors and therapeutic management].
Topics: Animals; Antiprotozoal Agents; Drug Resistance; Female; Humans; Immunity, Cellular; Infant; Interferon-gamma; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentamidine; Recurrence | 1996 |
Action of pentamidine-bound nanoparticles against Leishmania on an in vivo model.
Topics: Animals; Antimony; Antiprotozoal Agents; Colloids; Disease Models, Animal; Drug Carriers; Female; Leishmania major; Leishmaniasis, Visceral; Liver; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Microspheres; Organometallic Compounds; Pentamidine; Polymethacrylic Acids; Random Allocation | 1994 |
Efficacy of second line drugs on antimonyl-resistant amastigotes of Leishmania infantum.
Topics: Amphotericin B; Animals; Antimony Potassium Tartrate; Antiprotozoal Agents; Cell Line; Drug Resistance; Humans; Leishmania infantum; Meglumine; Meglumine Antimoniate; Mutation; Organometallic Compounds; Pentamidine | 2000 |
[Epidemics of cutaneous leishmaniasis in military personnel working in French Guiana].
Topics: Antiprotozoal Agents; Bedding and Linens; Clothing; French Guiana; Humans; Insect Repellents; Insecticides; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Military Personnel; Organometallic Compounds; Pentamidine; Recurrence; Skin; Trees | 2000 |
Flow cytometry, a useful tool for detecting the lethal effect of pentamidine on Leishmania viannia complex promastigote forms.
Topics: Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Drug Resistance; Flow Cytometry; Humans; Leishmania guyanensis; Macrophages; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentamidine; Propidium; Sensitivity and Specificity | 2001 |
An HIV-positive man with tattoo induration.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Animals; Antiprotozoal Agents; Biopsy, Needle; Drug Therapy, Combination; Follow-Up Studies; HIV Seropositivity; Humans; Immunohistochemistry; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pentamidine; Recurrence; Risk Assessment; Tattooing | 2007 |
Cutaneous and mucocutaneous leishmaniasis in Tigray, northern Ethiopia: clinical aspects and therapeutic concerns.
Topics: Adolescent; Adult; Antiprotozoal Agents; Child; Child, Preschool; Ethiopia; Female; HIV Infections; HIV-1; Humans; Infant; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pentamidine; Socioeconomic Factors; Young Adult | 2009 |
[Raised tattoos in a human-immunodeficiency-virus-infected patient].
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiprotozoal Agents; Antiretroviral Therapy, Highly Active; CD4-Positive T-Lymphocytes; Hepatitis C, Chronic; Histiocytes; Humans; Lamivudine; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Lopinavir; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Patient Compliance; Pentamidine; Pyrimidinones; Recurrence; Ritonavir; Tattooing; Zidovudine | 2009 |
Mucosal leishmaniasis: description of case management approaches and analysis of risk factors for treatment failure in a cohort of 140 patients in Brazil.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Antiprotozoal Agents; Brazil; Case Management; Cohort Studies; Female; Humans; Hypertension; Itraconazole; Leishmania braziliensis; Leishmaniasis, Mucocutaneous; Logistic Models; Male; Meglumine; Middle Aged; Pentamidine; Retrospective Studies; Risk Factors; Secondary Prevention; Skin; Treatment Failure; Young Adult | 2009 |
Comment on: Cutaneous and mucocutaneous leishmaniasis in Tigray, northern Ethiopia: clinical aspects and therapeutic concerns.
Topics: Antiprotozoal Agents; Ethiopia; Humans; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Meglumine; Pentamidine | 2010 |
The influence of treatment on the development of leishmaniasis recidiva cutis: a 17-year case-control study in Midwestern Brazil.
Topics: Adolescent; Adult; Amphotericin B; Brazil; Case-Control Studies; Female; Humans; Incidence; Leishmaniasis, Cutaneous; Longitudinal Studies; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pentamidine; Recurrence; Retrospective Studies; Risk Factors; Time Factors; Trypanocidal Agents; Young Adult | 2015 |